Register Here
8:45 Welcome
Chair: Prof. Serge Rozenberg (ULB Brussels)
9:00 Physiopathology of vasomotor symptoms.
Prof. Axelle Pintiaux (U Liège)
9:30 Why, how and when not using MHT.
Dr. Linda Ameryckx (UZ Antwerp)
10:00 Brain effects of anti-hormones.
Prof. Herman Depypere (UZ Ghent)
10:00 – 10:30 Coffee & visit to booths
10:30 When hormone can’t be used
Prof. Axelle Pintiaux (U Liège)
11.00 Satellite meeting
Fezolinetant (VEOZATM):
Are NK3R inhibitors a new paradigm in the management of menopause related VMS?
• Introduction and moderator:
Dr. Anne Firquet (hôpital Citadelle,
centre de la ménopause, Liège)
• NK3 Receptors/Thermoregulation and
Fezolinetant – mode of action: prof. Herman
Depypere (UZ Ghent)
• Clinical data from the Phase III SKYLIGHT studies:
prof. Serge Rozenberg (ULB Brussels)
• Conclusions & take home messages:
Dr. Anne Firquet (hôpital Citadelle,
centre de la ménopause, Liège)
Site of the meeting
CHU Saint-Pierre – UMC Sint-Pieter
Rue Haute 322 Hoogstraat
Bâtiment FORUM Gebouw
1000 BRUSSELS
Parking is available
Accreditation will be asked